KalshiVerfügbarkeit prüfenKYC erforderlich2% GebührVerifizierte AuflösungsdatenGrob kalibriertAktuelle implizite WahrscheinlichkeitBefore October 2027 90%Führend unter 5 Optionen
Marktqualitat
48 / 100
Niedrige Qualität24h-Volumen
0 €
Liquidität
6514,6 €
Mittlere LiquiditätGeld / Brief
32.0% / 36.0%
Spread
4.0 pt
Mittlerer SpreadMarktdaten
Aktualisiert vor 13 Minuten
16. Mai 26, 2:301. Jan. 27, 4:59
Trends
Nur virtuelles Guthaben – kein echtes GeldKeine Finanzberatung
Gewähltes Ergebnis
Before Jan 1, 202736%
Volumentrend
$132. Juli20T Daten27. Juli
Verwandte Märkte
Hantavirus pandemic in 2026?
98.414,7 €Ja: 3%
POLYMARKET
POLYMARKET
# of views of MrBeast video day 3?
6853,4 €26-27M: 78%POLYMARKET
POLYMARKET
New pandemic in 2026?
5203,8 €Ja: 9%POLYMARKET
POLYMARKET
Measles cases in 2026?
2438,5 €Above 3000: 94%KALSHI
KALSHI
Pandemic in 2026?
2038,4 €Ja: 5%KALSHI
KALSHI
Cyclosporiasis cases reported in the US in 2026?
1162,7 €Above 20k: 34%KALSHI
KALSHIIn diesen Themen aktiv
Regeln
If the FDA approves COMP360 Psilocybin for Treatment-Resistant Depression for marketing before Jan 1, 2027, then the market resolves to Yes.
- If the FDA approves COMP360 Psilocybin for Treatment-Resistant Depression for marketing before Mar 1, 2027, then the market resolves to Yes.
- If the FDA approves COMP360 Psilocybin for Treatment-Resistant Depression for marketing before Jul 1, 2027, then the market resolves to Yes.
- If the FDA approves COMP360 Psilocybin for Treatment-Resistant Depression for marketing before Oct 1, 2027, then the market resolves to Yes.
- If the FDA approves COMP360 Psilocybin for Treatment-Resistant Depression for marketing before Jan 1, 2028, then the market resolves to Yes.